| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1028616191 |
| P356 | DOI | 10.1186/AR4502 |
| P932 | PMC publication ID | 4060174 |
| P698 | PubMed publication ID | 24612981 |
| P5875 | ResearchGate publication ID | 260681849 |
| P50 | author | Perla Abigail Alvarado-Vazquez | Q87823534 |
| Aracely Chávez-Piña | Q81770526 | ||
| P2093 | author name string | Juan M Jimenez-Andrade | |
| Ana M Torres-Guzman | |||
| Carlos E Morado-Urbina | |||
| Rosa I Acosta-Gonzalez | |||
| Rosa M Montiel-Ruiz | |||
| P2860 | cites work | Possible involvement of β-endorphin in docosahexaenoic acid-induced antinociception | Q84318138 |
| Docosahexaenoic acid, an omega-3 polyunsaturated acid protects against indomethacin-induced gastric injury | Q87439536 | ||
| Novel chemical mediators in the resolution of inflammation: resolvins and protectins | Q28200237 | ||
| Involvement of the long-chain fatty acid receptor GPR40 as a novel pain regulatory system | Q28254526 | ||
| Ethical guidelines for investigations of experimental pain in conscious animals | Q29617510 | ||
| Evolving concepts of rheumatoid arthritis | Q29618020 | ||
| Verbal pain descriptors used by patients with arthritis | Q33555827 | ||
| Evaluating intra-articular drug delivery for the treatment of osteoarthritis in a rat model | Q33634515 | ||
| Omega-3 polyunsaturated fatty acids and immune-mediated diseases: inflammatory bowel disease and rheumatoid arthritis | Q34090424 | ||
| Influence of marine n-3 polyunsaturated fatty acids on immune function and a systematic review of their effects on clinical outcomes in rheumatoid arthritis. | Q34275364 | ||
| n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases | Q34569101 | ||
| Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils | Q34621152 | ||
| Mechanisms of pain in arthritis | Q34735644 | ||
| Epidemiology of rheumatoid arthritis: determinants of onset, persistence and outcome. | Q35021039 | ||
| The effect of aging on the density of the sensory nerve fiber innervation of bone and acute skeletal pain | Q35040554 | ||
| Day and night pain measurement in rheumatoid arthritis | Q35548003 | ||
| Burden of major musculoskeletal conditions. | Q35622610 | ||
| Resolvin D2 is a potent endogenous inhibitor for transient receptor potential subtype V1/A1, inflammatory pain, and spinal cord synaptic plasticity in mice: distinct roles of resolvin D1, D2, and E1. | Q35623911 | ||
| An evidence-based update on nonsteroidal anti-inflammatory drugs | Q35758411 | ||
| Neuroplasticity of sensory and sympathetic nerve fibers in a mouse model of a painful arthritic joint | Q36067194 | ||
| Pathogenesis and management of pain in osteoarthritis. | Q36070771 | ||
| Endogenous opioids inhibit early-stage pancreatic pain in a mouse model of pancreatic cancer | Q36178615 | ||
| A meta-analysis of the efficacy and toxicity of combining disease-modifying anti-rheumatic drugs in rheumatoid arthritis based on patient withdrawal | Q36200678 | ||
| Sensory and sympathetic nerve fibers undergo sprouting and neuroma formation in the painful arthritic joint of geriatric mice | Q36245918 | ||
| Advances in the treatment of inflammatory arthritis | Q36288599 | ||
| Intraarticular drug delivery in osteoarthritis | Q36436048 | ||
| The burden of musculoskeletal disease--a global perspective | Q36446201 | ||
| Pain treatment in arthritis-related pain: beyond NSAIDs | Q36481613 | ||
| A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain | Q36750401 | ||
| Toxicology and safety of DHA. | Q37509922 | ||
| Intraarticular treatments for osteoarthritis: new perspectives | Q37701907 | ||
| Intra-articular drug delivery: The challenge to extend drug residence time within the joint | Q37800272 | ||
| Osteoclasts in arthritis and Th17 cell development | Q37809897 | ||
| Current view of glucocorticoid co-therapy with DMARDs in rheumatoid arthritis | Q37814078 | ||
| Adverse drug events in rheumatoid arthritis and osteoarthritis ambulatory patients | Q38019625 | ||
| Cyclooxygenase-2 induction in macrophages is modulated by docosahexaenoic acid via interactions with free fatty acid receptor 4 (FFA4). | Q39100149 | ||
| Antinociceptive effects of docosahexaenoic acid against various pain stimuli in mice | Q39284980 | ||
| Docosahexaenoic acid attenuates macrophage-induced inflammation and improves insulin sensitivity in adipocytes-specific differential effects between LC n-3 PUFA. | Q39433910 | ||
| Docosahexaenoic acid is more potent inhibitor of osteoclast differentiation in RAW 264.7 cells than eicosapentaenoic acid | Q40069286 | ||
| TRPV1 is a novel target for omega-3 polyunsaturated fatty acids | Q40220632 | ||
| Osteoclasts play a part in pain due to the inflammation adjacent to bone | Q40268820 | ||
| The costs of musculoskeletal disease: health needs assessment and health economics | Q40557608 | ||
| Local ASIC3 modulates pain and disease progression in a rat model of osteoarthritis | Q42091565 | ||
| The effects of polyunsaturated fatty acids and their metabolites on osteoclastogenesis in vitro | Q43098236 | ||
| Septic arthritis of the knee following intraarticular injections in elderly patients: report of six patients | Q43803223 | ||
| Docosahexaenoic acid reduces inflammation and joint destruction in mice with collagen-induced arthritis | Q44060152 | ||
| In vivo characterization of 6beta-naltrexol, an opioid ligand with less inverse agonist activity compared with naltrexone and naloxone in opioid-dependent mice | Q44348131 | ||
| A robust model of adjuvant-induced chronic unilateral arthritis in two mouse strains | Q45109590 | ||
| The quality of pain in arthritis: the words patients use to describe overall pain and pain in individual joints at rest and on movement | Q45300422 | ||
| Monoarticular corticosteroid injection versus systemic administration in the treatment of rheumatoid arthritis patients: a randomized double-blind controlled study. | Q45994411 | ||
| Long-term moderate intervention with n-3 long-chain PUFA-supplemented dairy products: effects on pathophysiological biomarkers in patients with rheumatoid arthritis | Q46107800 | ||
| Trends in medical care expenditures of US adults with arthritis and other rheumatic conditions 1997 to 2005. | Q46324674 | ||
| Effects of free fatty acids on sodium currents in rat dorsal root ganglion neurons | Q47774073 | ||
| Different effects of 7-nitroindazole in reserpine-induced hypolocomotion in two strains of mice. | Q48613390 | ||
| Toxicologic evaluation of DHA-rich algal oil: Genotoxicity, acute and subchronic toxicity in rats | Q50024949 | ||
| Effect of n-3 polyunsaturated fatty acid supplementation in patients with rheumatoid arthritis: a 16-week randomized, double-blind, placebo-controlled, parallel-design multicenter study in Korea. | Q53344987 | ||
| Spinal injection of docosahexaenoic acid attenuates carrageenan-induced inflammatory pain through inhibition of microglia-mediated neuroinflammation in the spinal cord. | Q54268055 | ||
| Rheumatoid arthritis | Q56656479 | ||
| Antinociceptive and anti-inflammatory potential of extract and isolated compounds from the leaves of Salvia officinalis in mice | Q63197607 | ||
| Anti-inflammatory properties of docosahexaenoic and eicosapentaenoic acids in phorbol-ester-induced mouse ear inflammation | Q71776051 | ||
| Chondroclasts and osteoclasts at subchondral sites of erosion in the rheumatoid joint | Q72824611 | ||
| Peripheral beta-endorphin in rheumatoid arthritis. A correlation with the disease activity | Q73310695 | ||
| Docosahexanoic acid (DHA) improved glucose and lipid metabolism in KK-Ay mice with genetic non-insulin-dependent diabetes mellitus (NIDDM) | Q73404519 | ||
| Polyunsaturated fatty acids and inflammation | Q79860384 | ||
| Effects of a monoclonal antibody raised against nerve growth factor on skeletal pain and bone healing after fracture of the C57BL/6J mouse femur | Q80635082 | ||
| P433 | issue | 2 | |
| P921 | main subject | sensory perception of pain | Q2734305 |
| P304 | page(s) | R64 | |
| P577 | publication date | 2014-03-10 | |
| P1433 | published in | Arthritis Research and Therapy | Q15757229 |
| P1476 | title | Chronic oral or intraarticular administration of docosahexaenoic acid reduces nociception and knee edema and improves functional outcomes in a mouse model of Complete Freund's Adjuvant-induced knee arthritis | |
| P478 | volume | 16 |
| Q64117374 | Activation of GPR40 produces mechanical antiallodynia via the spinal glial interleukin-10/β-endorphin pathway |
| Q87417860 | Early, middle, or late administration of zoledronate alleviates spontaneous nociceptive behavior and restores functional outcomes in a mouse model of CFA-induced arthritis |
| Q36218707 | Eicosapentaenoic acid and docosapentaenoic acid monoglycerides are more potent than docosahexaenoic acid monoglyceride to resolve inflammation in a rheumatoid arthritis model |
| Q34115288 | Metabolic enrichment of omega-3 polyunsaturated fatty acids does not reduce the onset of idiopathic knee osteoarthritis in mice |
| Q42374117 | Polyunsaturated fatty acids: any role in rheumatoid arthritis? |
| Q38631467 | Repeated administration of mazindol reduces spontaneous pain-related behaviors without modifying bone density and microarchitecture in a mouse model of complete Freund's adjuvant-induced knee arthritis. |
| Q39866382 | Risk of secondary lymphedema in breast cancer survivors is related to serum phospholipid fatty acid desaturation. |
| Q28248377 | The role of long chain fatty acids and their epoxide metabolites in nociceptive signaling |
Search more.